Drug Search Results
More Filters [+]

Avobenzone

Alternative Names: avobenzone, anthelios 20, anthelios 40, capital soleil 15, anthelios sx, shade uvaguard, la roche posay laboratoire dermatologique anthelios sx daily moisturizing sunscreen broad spectrum spf 15
Latest Update: 2023-05-18
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: UV Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Approved

Approved Countries: Bangladesh | India | Ireland | Pakistan | United Arab Emirates | United States

Approved Indications: None

Known Adverse Events: None

Company: Food and Drug Administration (FDA)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Avobenzone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

SCR-005

P1

Completed

Healthy Volunteers

2019-02-18

NCT05865431

N/A

Completed

Skin Cancer

2018-02-02

Recent News Events

Date

Type

Title